Literature DB >> 34077701

Formononetin attenuates H2O2-induced cell death through decreasing ROS level by PI3K/Akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells.

Mayuko Sugimoto1, Risa Ko1, Hiromi Goshima1, Atsushi Koike1, Makio Shibano2, Ko Fujimori3.   

Abstract

Formononetin is an isoflavone, found in herbs like Trifolium pratense, which executes a variety of physiological activities including anti-neurodegenerative effect. However, the molecular mechanism of formononetin-mediated neuroprotection remains unclear. In this study, we investigated the protective effect of formononetin on hydrogen peroxide (H2O2)-induced death of human neuroblastoma SH-SY5Y cells and its underlying molecular mechanism. Formononetin suppressed H2O2-induced cytotoxicity. H2O2-induced increase in the intracellular reactive oxygen species (ROS) levels was decreased by formononetin, together with the enhanced expression of the antioxidant genes. H2O2-induced elevation of the Bax/Bcl-2 ratio and cleaved caspase-3 and caspase-7 levels were lowered by formononetin treatment. Moreover, formononetin repressed H2O2-induced phosphorylation of mitogen-activated protein kinases (MAPKs). Nuclear factor erythroid 2-related factor 2 (Nrf2) siRNA decreased antioxidant gene expression and elevated the H2O2-induced ROS level in the formononetin-treated cells. Furthermore, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling is involved in the activation of the nuclear translocation of Nrf2. These results indicate that the neuroprotective effect of formononetin against H2O2-induced cell death is due to a decrease in the ROS level with the enhanced expression of the antioxidant genes through activation of the PI3K/Akt-Nrf2 signaling. In addition, formononetin suppressed apoptosis through inhibition of phosphorylation of MAPKs in SH-SY5Y cells. Thus, formononetin is a potential therapeutic agent for the treatment of neurodegenerative diseases.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell death; Formononetin; MAPK; PI3K/Akt; ROS; SH-SY5Y

Mesh:

Substances:

Year:  2021        PMID: 34077701     DOI: 10.1016/j.neuro.2021.05.014

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  5 in total

Review 1.  Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity.

Authors:  Xiaowei Xu; Liqun Jia; Xiaoran Ma; Huayao Li; Changgang Sun
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

2.  Ginsenoside Rk1 protects human melanocytes from H2O2‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway.

Authors:  Jian Xiong; Jianing Yang; Kai Yan; Jing Guo
Journal:  Mol Med Rep       Date:  2021-09-24       Impact factor: 2.952

3.  Formononetin Protects LPS-Induced Mastitis Through Suppressing Inflammation and Enhancing Blood-Milk Barrier Integrity via AhR-Induced Src Inactivation.

Authors:  Kaihe Xiang; Peng Shen; Ziyang Gao; Zhuoyu Liu; Xiaoyu Hu; Bin Liu; Yunhe Fu
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

4.  Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis.

Authors:  Ning Wu; Taohua Yuan; ZhiXin Yin; Xiaotian Yuan; Jianfei Sun; Zunqiu Wu; Qilong Zhang; Carl Redshaw; Shenggang Yang; Xiaotian Dai
Journal:  Drug Des Devel Ther       Date:  2022-02-19       Impact factor: 4.162

5.  Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPAR-γ signaling based on network pharmacology and experimental validation.

Authors:  Baohua Zhang; Zhongwei Hao; Wenli Zhou; Shan Zhang; Mingyan Sun; Honglei Li; Naijing Hou; Cui Jing; Mingxing Zhao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.